Early research (Phase 1)Study completedNCT07473752
What this trial is testing
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TNX-1500 in Healthy Subjects
Who this might be right for
Phase 1 First-in-human Study Involving Healthy Subjects
Tonix Pharmaceuticals, Inc. 26